Abdullah Esmail

33PUBLICATIONS
40CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 27, 2026
Next-Generation Immune Checkpoint Inhibitors in Gastrointestinal Cancers: Mechanisms, Resistance, and Emerging Therapeutic Strategies.

|Jul 28, 2026
Prognostic Impact of Baseline Circulating Tumor DNA (ctDNA) in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

|Jul 28, 2026
Comparing the Effectiveness and Safety of Different Third-Line Management Options for Patients with Metastatic Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis.

|Jul 15, 2026
Comprehensive Safety and Efficacy Evaluation of Immunotherapy Combination Approaches Versus Tyrosine Kinase Inhibitor Monotherapy as First-Line Treatment of Hepatocellular Carcinoma: A Network and Individual Patient Data (IPD) Meta-Analysis.

|Dec 30, 2025
Atezolizumab Plus Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma: An Institutional Experience.

Abdullah Esmail, Yazan Hamadneh, Bayan Khasawneh

|Sep 15, 2025
Tumor-informed circulating tumor DNA assay for surveillance post-liver transplantation in patients with hepatocellular and cholangiocarcinoma.

Maen Abdelrahim, Ashton A Connor, Abdullah Esmail

Pageof 6

Frequent Collaborators

4 joint publications

Godsfavour Umoru

4 joint publications

Maen Abdelrahim

3 joint publications

Ala Abudayyeh

2 joint publications

Ashish Saharia